Your browser doesn't support javascript.
loading
Voluntary early retirement and mortality in patients with and without chronic diseases: a nationwide Danish Registry study.
Jacobsen, P A; Kragholm, K; Andersen, M P; Lindgren, F L; Ringgren, K B; Torp-Pedersen, C; Weinreich, U M.
Affiliation
  • Jacobsen PA; Department of Respiratory Diseases, Aalborg University Hospital, Aalborg, Denmark; The Clinical Institute, Aalborg University, Aalborg, Denmark. Electronic address: peter.jacobsen@rn.dk.
  • Kragholm K; The Clinical Institute, Aalborg University, Aalborg, Denmark; Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
  • Andersen MP; Department of Cardiology, Nordsjællands Hospital, Hillerød, Denmark.
  • Lindgren FL; The Clinical Institute, Aalborg University, Aalborg, Denmark; Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
  • Ringgren KB; The Clinical Institute, Aalborg University, Aalborg, Denmark; Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
  • Torp-Pedersen C; Department of Cardiology, Nordsjællands Hospital, Hillerød, Denmark.
  • Weinreich UM; Department of Respiratory Diseases, Aalborg University Hospital, Aalborg, Denmark; The Clinical Institute, Aalborg University, Aalborg, Denmark.
Public Health ; 211: 114-121, 2022 Oct.
Article in En | MEDLINE | ID: mdl-36088807
OBJECTIVE: This study explores how the choice of voluntary early retirement (VER) affects mortality in a population where VER is available 5 years before regular retirement age. STUDY DESIGN: This retrospective cohort study uses a registry-based follow-up design with access to Nationwide Danish Registry Data. METHODS: The study includes all Danish individuals who between 2000 and 2015 were part of an unemployment insurance fund and working at the time of their 60th (P60) or 62nd (P62) birthday. Those alive 1 year from their 60th or 62nd birthday were included in the mortality analysis. Individuals were registered as VER recipients if they chose the benefit within 1 year from P60 or P62. Three-year mortality likelihood following the first year from inclusion was explored for both cohorts separately. Multiple subgroups were explored in the mortality analysis, including individuals with chronic obstructive pulmonary disease (COPD), heart failure, and diabetes. RESULTS: P60 included 627,278 individuals, and VER was chosen by 22.5%. P62 included 379,196 individuals, and VER was chosen by 33.4%. The likelihood of VER in the P60 was lower in healthy individuals (odds ratio [OR] 0.87, confidence interval [CI] 0.85-0.88) and higher in COPD (OR 1.15, CI 1.07-1.22) and heart failure patients (OR 1.15, CI 1.05-1.25). Three-year mortality was significantly higher in those choosing VER in P60 (OR 1.28, CI 1.22-1.34), which was also found for all health subgroups (healthy, OR 1.18, CI 1.07-1.30; COPD, OR 1.55, CI 1.16-2.07; heart failure, OR 1.42, CI 1.02-1.98; diabetes, OR 1.36, CI 1.12-1.65). The increased mortality risk was not found in the P62 cohort. CONCLUSION: The choice of VER is more likely in patients with COPD and heart failure. VER in the P60 cohort is associated with an increased mortality likelihood, which was not found in the P62 cohort, which may be explained by health selection bias.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Pulmonary Disease, Chronic Obstructive / Diabetes Mellitus / Heart Failure Type of study: Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Public Health Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Main subject: Pulmonary Disease, Chronic Obstructive / Diabetes Mellitus / Heart Failure Type of study: Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Public Health Year: 2022 Type: Article